Bolt Biotherapeutics, Inc.
BOLT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001641281
In the last 90 days, Bolt Biotherapeutics, Inc. insiders filed 2 open-market purchases and 3 sales; 23 institutions reported holding it in 13F filings for Q2 2026, worth $2.31M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Bolt Biotherapeutics, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 56 | 44 | −12 |
| Shares | 26.8M | 20.6M | −6.20M (−23.1%) |
| Value | $39.7M | $26.8M | −$12.9M (−32.5%) |
New holders (1)
Institutions that held Bolt Biotherapeutics, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 20,307 | $26.4K | 0.00% |
Sold out (13)
Institutions that held Bolt Biotherapeutics, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Novo Holdings A/S | 3,703,991 | $5.48M |
| Suvretta Capital Management, LLC | 2,672,000 | $3.96M |
| Ra Capital Management, L.P. | 533,432 | $789.0K |
| Caas Capital Management LP | 116,777 | $173.0K |
| Bailard, Inc. | 46,383 | $69.0K |
| Gsa Capital Partners LLP | 35,561 | $53.0K |
| Occudo Quantitative Strategies LP | 25,380 | $38.0K |
| Schonfeld Strategic Advisors LLC | 19,200 | $29.0K |
| Qube Research & Technologies Ltd | 19,286 | $29.0K |
| Dimensional Fund Advisors LP | 10,071 | $15.0K |
| Cubist Systematic Strategies, LLC | 10,228 | $15.0K |
| China Universal Asset Management Co., Ltd. | 353 | $1.00K |
| Ellevest, Inc. | 32 | $0 |